Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

240. New Antimicrobial Drug Development: Saturday, 12:15 - 1:30 p.m.

Poster Session: New Antimicrobial Drug Development

(2513) CERTAIN-1 Subgroup Analysis: A Phase 3 Study of Cefepime-Taniborbactam Efficacy in the Treatment of Complicated Urinary Tract Infections (cUTI)

Saturday, October 14, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C